phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Atheroma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jallouk, AP; Myerson, JW; Palekar, RU; Pan, H; Wickline, SA | 1 |
1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Atheroma
Article | Year |
---|---|
Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antithrombins; Apolipoproteins E; Atherosclerosis; Blood Coagulation; Capillary Permeability; Carotid Artery Injuries; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Humans; Inflammation Mediators; Magnetic Resonance Spectroscopy; Male; Mice, Knockout; Nanoparticles; Plaque, Atherosclerotic; Signal Transduction; Thrombin; Thrombosis; Time Factors | 2016 |